ZLABZai Lab Limited

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$101M+45.9% YoY

Gross Profit

$65M64.9% margin

Operating Income

-$76M-75.7% margin

Net Income

-$80M-79.9% margin

EPS (Diluted)

$-8.20

QoQ Revenue Growth

+15.3%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$987M

Total Liabilities

$283M

Stockholders' Equity

$704M

Cash & Equivalents

$630M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$101M	$69M	+45.9%
Gross Profit	$65M	$45M	+44.7%
Operating Income	-$76M	-$90M	+15.0%
Net Income	-$80M	-$121M	+33.6%

ZLAB Q2 2024 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena